Indolyl derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S374000, C514S419000, C548S204000, C548S235000, C548S465000

Reexamination Certificate

active

07098228

ABSTRACT:
The present invention provides compounds of formula Ias well as pharmaceutically acceptable salts and esters thereof, wherein R1to R4, A and n have the significance given in the specification. The compounds or their salts may be administered to a patient for treating non-insulin dependent diabetes mellitus.

REFERENCES:
patent: 4011326 (1977-03-01), Jensen
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 5089514 (1992-02-01), Hulin
patent: 5599826 (1997-02-01), Mertens et al.
patent: 5811439 (1998-09-01), Ogawa
patent: 5856529 (1999-01-01), Catt et al.
patent: 6004996 (1999-12-01), Shah et al.
patent: 6121397 (2000-09-01), MacLeod et al.
patent: 6291685 (2001-09-01), Junghans et al.
patent: 6441185 (2002-08-01), Kühnle et al.
patent: 6903104 (2005-06-01), Chen et al.
patent: 6903117 (2005-06-01), Farina et al.
patent: 6911465 (2005-06-01), Faull et al.
patent: 6933316 (2005-08-01), Hsieh et al.
patent: 6949566 (2005-09-01), Watanabe et al.
patent: 6960605 (2005-11-01), Wagle et al.
patent: 0 047 358 (1982-03-01), None
patent: 185359 (1986-06-01), None
patent: 189577 (1986-08-01), None
patent: 443449 (1991-08-01), None
patent: 524495 (1993-01-01), None
patent: 0 780 389 (1997-06-01), None
patent: 0903343 (1999-03-01), None
patent: 1 078 923 (2001-02-01), None
patent: WO 91/19702 (1991-12-01), None
patent: WO 94/01420 (1994-01-01), None
patent: WO 94/13650 (1994-06-01), None
patent: WO 95/17394 (1995-06-01), None
patent: WO 97/25042 (1997-07-01), None
patent: WO 99/08501 (1999-02-01), None
patent: WO 99/10339 (1999-03-01), None
patent: WO 00 08002 (2000-02-01), None
patent: WO 00/09122 (2000-02-01), None
patent: WO 00/09123 (2000-02-01), None
patent: WO 0100603 (2001-01-01), None
patent: WO 02 16331 (2002-02-01), None
patent: WO 02 092084 (2002-11-01), None
patent: WO 03/004458 (2003-01-01), None
patent: WO 03/053976 (2003-07-01), None
Keller and Wahli: Trends Endocrin. Metab. (1993); 4:291-296.
MacDougald and Lane: Current Biology vol. 5 pp. 618-621 (1995).
Guerre-Millo, et. al.; J Biol Chem2000; 275: 16638-16642.
Balfour, et. al.; Drugs 57 (1999) 921-930.
Haigh et. al., Tetrahedron: Asymmetry, 10, pp. 1353-1367.
Gotteland et al., Synlett, 9 pp. 931-932 (1995).
Hulin et al., J. Med. Chem., 39, pp. 3897-3907 (1996).
Nicolaou et al., J. Am. Chem. Soc., 122, pp. 3830-3838 (2000).
Nichols et al., Anal. Biochem., 257, pp. 112-119 (1998).
Einsiedel et. al., Bioorg. Med. Chem. Lett., 10, pp. 2041-2044 (2000).
Goto et al., Chem. Pharm. Bull., 19, pp. 2050-2057 (1971).
Reichstein et al., Helvetica Chimica Acta, 16, pp. 121-129 (1933).
Diels et al., chem.. Ber., 48, pp. 897-905 (1915).
Wightman et al., J. Org. chem.., 43, pp. 2167-2170 (1978).
Musser et al., J. Med. Chem. 30, pp. 62-67 (1987).
Rahman et al., J. Chem. Soc. Perkin Trans. 1, 12, pp. 2973-2977 (1983).
Kelly et. al., J. Am. Chem. Soc., 110, pp. 6471-6480 (1988).
Kneen et al., Synthetic Communications, 16, pp. 1635-1640 (1986).
Kim et al., Can. J. Chem., 60, pp. 2093-2098 (1982).
Pàrkànyi et al., Monatsh. Chem., 123, pp. 637-645 (1992).
STN International ® CAPLUS Database, Accession No. 2000; 117035; Collins et al., WO 2000008002, abstract.
Malamas, MS et al, Eur. J. Med. Chem. vol. 36, No. 1 (2001) pp. 31-42.
Hulin, B. et al., Current Pharmaceutical Design, vol. 2 (1996) pp. 85-102.
Oplinger, et. al., ACS National Meeting, San Diego, Apr. 1-5, 2001, Poster 238, Division of Medicinal Chemistry, Section C.
Gustavsson, et. al., Chemical Abstracts, vol. 138, No. 106,504 (2003).
Rami H K et al: “Synthetic ligands for PPAR gamma-review of patent literature 1994-1999” Expert Opinion on Therapeutic Patents, vol. 10(5) 2000, pp. 623-633.
Henke B R et al, Bioorganic & Medicinal Chemistry Letters vol. 9,(23) pp. 3329-3334 (Dec. 1999).
Lean, M.E.J., et al, European Journal of Clinical Pharmacology, vol. 25, No. 1, pp. 41-45 (1983).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Indolyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indolyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolyl derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3666577

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.